Medical device VCs have had to sit on the sidelines while biopharma VCs saw their start-ups make their way onto the public markets through initial public offerings of stock. But last month’s filing by LDR Holding Corp. could give device investors something to cheer about. No venture-backed spine start-up has staged a successful initial public offering in the US since TranS1 Inc. went public in 2007. [See Deal] The Austin, TX-based company, also known as LDR Spine, looking to end the drought, filed to raise up to $69 million from public investors. [See Deal]
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?